Status:
UNKNOWN
Abscess Aspiration
Lead Sponsor:
Wayne State University
Conditions:
Skin Abscess
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Incision and drainage (I\&D) is the standard guideline treatment of uncomplicated skin abscesses (a boil or bumo beneath the skin). Ultrasound-guided needle aspiration (USGNA) is a minimally invasive ...
Eligibility Criteria
Inclusion
- Non-toxic patients who present with an uncomplicated, superficial skin abscess of the head/neck, torso, extremities, and buttock will be eligible for inclusion.
- Abscesses must be verified by physical examination and bedside ultrasound.
- Patients with clinical history of diabetes mellitus and previous diagnosis of MRSA will be included.
Exclusion
- Patients will be excluded if age less than age 18 or pregnant.
- Patient or legal guardian is unable to give consent.
- Patients with no means of clinical follow-up will be excluded.
- Complicated abscesses, defined as an abscess with associated sepsis, lymphangitis, or osteomyelitis, requiring intravenous antibiotic therapy, requiring hospital admission, previous surgical drainage at site of abscess, overlying skin lesion/fistula/ulceration with the exception of cellulitis, perforated or actively draining abscess, duration of symptoms \> 5 days,1,28 and/or multiple concurrent abscesses that can be clinically regarded as chronic in nature will be excluded.
- 4\) Abscess locations which will be excluded are dental, peritonsillar, anorectal, genital/inguinal, axillary if suspicion for chronic hidradenitis suppurativa, or pilonidal/intragluteal at the base of the coccyx.
- 5\) Abscesses greater in size than 3x3x3 cm in any dimension will be excluded. \[It has been suggested extensively in the surgical literature that an abscess diameter \>3 cm should have surgical/catheter-drainage as the initial management instead of needle aspiration\]2,5,15,19,27,33 \[It has been reported that abscesses \>3 cm in size have increased failure rates\]15 6) Abscess depth is greater than maximal needle length. 7) Patients with immunosuppression from following clinical conditions will be excluded: HIV, cancer on active chemotherapy.
- 8\) Patients with active history of IV drug use will be excluded.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04127071
Start Date
June 1 2020
End Date
December 31 2020
Last Update
May 19 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.